166 related articles for article (PubMed ID: 34571024)
1. High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic.
Isachenko V; Isachenko E; Mallmann P; Rahimi G
Cryobiology; 2021 Dec; 103():1-6. PubMed ID: 34571024
[TBL] [Abstract][Full Text] [Related]
2. The Impact of SARS-CoV-2 on Sperm Cryostorage, Theoretical or Real Risk?
Anifandis G; Taylor TH; Messini CI; Chatzimeletiou K; Daponte A; Ioannou D; Tempest HG
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577870
[TBL] [Abstract][Full Text] [Related]
3. Patient with ovarian insufficiency: baby born after anticancer therapy and re-transplantation of cryopreserved ovarian tissue.
Isachenko V; Morgenstern B; Todorov P; Isachenko E; Mallmann P; Hanstein B; Rahimi G
J Ovarian Res; 2020 Sep; 13(1):118. PubMed ID: 32993734
[TBL] [Abstract][Full Text] [Related]
4. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 vs. human gametes, embryos and cryopreservation.
Anifandis G; Messini CI; Simopoulou M; Sveronis G; Garas A; Daponte A; Messinis IE
Syst Biol Reprod Med; 2021 Aug; 67(4):260-269. PubMed ID: 34060390
[TBL] [Abstract][Full Text] [Related]
6. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.
Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE
Front Immunol; 2022; 13():937900. PubMed ID: 36203566
[TBL] [Abstract][Full Text] [Related]
7. Sperm cryopreservation during the SARS-CoV-2 pandemic.
Paoli D; Pallotti F; Nigro G; Aureli A; Perlorca A; Mazzuti L; Di Carlo D; Turriziani O; Lenzi A; Lombardo F
J Endocrinol Invest; 2021 May; 44(5):1091-1096. PubMed ID: 33040303
[TBL] [Abstract][Full Text] [Related]
8. Cell and Organism Technologies for Assessment of the SARS-CoV-2 Infectivity in Fluid Environment.
Shelemba AA; Kazachkova EA; Kononova YV; Kazachinskaya EI; Rukavishnikov MY; Kuvshinova IN; Voevoda MI; Shestopalov AM; Chepurnov AA
Bull Exp Biol Med; 2022 Aug; 173(4):519-522. PubMed ID: 36058968
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità).
Corona G; Baldi E; Isidori AM; Paoli D; Pallotti F; De Santis L; Francavilla F; La Vignera S; Selice R; Caponecchia L; Pivonello R; Ferlin A; Foresta C; Jannini EA; Lenzi A; Maggi M; Lombardo F
J Endocrinol Invest; 2020 Aug; 43(8):1153-1157. PubMed ID: 32462316
[TBL] [Abstract][Full Text] [Related]
10. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
[TBL] [Abstract][Full Text] [Related]
11. Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes.
Karavani G; Chill HH; Dick A; Meirman C; Gutman-Ido E; Herzberg S; Ben-Meir A; Imbar T
Reprod Biomed Online; 2022 Nov; 45(5):987-994. PubMed ID: 35953414
[TBL] [Abstract][Full Text] [Related]
12. Risk of contamination of semen, vaginal secretions, follicular fluid and ovarian medulla with SARS-CoV-2 in patients undergoing ART.
Kteily K; Pening D; Diaz Vidal P; Devos M; Dechene J; Op de Beeck A; Botteaux A; Janssens S; Van den Abbeel E; Goldrat O; Delbaere A; Demeestere I
Hum Reprod; 2022 Jan; 37(2):235-241. PubMed ID: 34741508
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting stability and infectivity of SARS-CoV-2.
Chan KH; Sridhar S; Zhang RR; Chu H; Fung AY; Chan G; Chan JF; To KK; Hung IF; Cheng VC; Yuen KY
J Hosp Infect; 2020 Oct; 106(2):226-231. PubMed ID: 32652214
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
16. Cryopreservation and IVF in the time of Covid-19: what is the best good tissue practice (GTP)?
Pomeroy KO; Schiewe MC
J Assist Reprod Genet; 2020 Oct; 37(10):2393-2398. PubMed ID: 32748306
[TBL] [Abstract][Full Text] [Related]
17. On the Origin of SARS-CoV-2: Did Cell Culture Experiments Lead to Increased Virulence of the Progenitor Virus for Humans?
Kaina B
In Vivo; 2021; 35(3):1313-1326. PubMed ID: 33910809
[TBL] [Abstract][Full Text] [Related]
18. Effect of different human tissue processing techniques on SARS-CoV-2 inactivation-review.
Paggiaro AO; Carvalho VF; Gemperli R
Cell Tissue Bank; 2021 Mar; 22(1):1-10. PubMed ID: 33033963
[TBL] [Abstract][Full Text] [Related]
19. Cryopreservation in reproductive medicine during the COVID-19 pandemic: rethinking policies and European safety regulations.
Alteri A; Pisaturo V; Somigliana E; Viganò P
Hum Reprod; 2020 Dec; 35(12):2650-2657. PubMed ID: 32744638
[TBL] [Abstract][Full Text] [Related]
20. [Detection and evaluation of SARS-CoV-2 nucleic acid contamination in corona virus disease 19 ward surroundings and the surface of medical staff's protective equipment].
Yuan XN; Meng QY; Shen N; Li YX; Liang C; Cui M; Ge QG; Li XG; Tan K; Chen Q; Wang J; Zeng XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):803-808. PubMed ID: 33047711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
